Circulation

Arthritis drug could be first to stop heart valve calcification

Jun. 13, 2017

Vanderbilt University

University Leadership
Residential Colleges
This Is Vanderbilt
Research@Vanderbilt

Working at Vanderbilt
Events
Logins
Campus Map
Media Resources

Nashville, Tennessee 37240

615-322-7311 • Contact Us

Vanderbilt University’s Online Privacy Notice

Twitter
Facebook
LinkedIn
Instagram
YouTube
TikTok
Flickr

Vanderbilt University is committed to the principle of equal opportunity. Vanderbilt University does not discriminate against individuals on the basis of their race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, military service, or genetic information in its administration of educational policies, programs, or activities; admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. Accessibility information. Vanderbilt®, Vanderbilt University® and the Vanderbilt logos are trademarks of The Vanderbilt University. Site Development: Digital Strategies (Communications and Marketing.) © 2025

Circulation

Arthritis drug could be first to stop heart valve calcification